Sector: Consumer Non-Cyclicals | Industry: Drug Retailers |
Company Contact | |
Address: | 82 Richmond Street East TORONTO ON M5C 1P1 |
Tel: | N/A |
Website: | https://www.blueberriesmed.com |
IR: | See website |
Key People | ||
N/A |
Business Overview |
Blueberries Medical Corp. is a Canada-based company, which is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. The Company is engaged in the growth, cultivation, and development of medicinal cannabis and related products with operations in Colombia. The Company is focused on processing and supplying medicinal-grade Cannabis oil extracts, medical flowers, and related products. It is developing and commercializing a range of cannabis-derived ingredients, including high and low tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. The Company's subsidiaries include Blueberries Research Corporation (BRC), Blueberries SAS (BBSAS), Centro De Desarrollo e Investigacion (CDIBBSAS), BBV Labs Inc. (BBV Labs.) and SATIN S.A.S. (SATIN). Blueberries SAS is a licensed producer and distributor of medicinal Cannabis and Cannabis-derived products in Colombia. |
Financial Overview |
For the fiscal year ended 31 December 2023, Blueberries Medical Corp revenues increased 22% to C$288K. Net loss increased 11% to C$1.6M. Revenues reflect Colombia segment increase of 4% to C$246K. Higher net loss reflects Changes of fair value of derivative liab decrease of 89% to C$58K (income), Director and management fees increase from C$84K to C$294K (expense). Basic Earnings per Share excluding Extraordinary Items remained flat at -C$0.01. |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $5.18M as of Dec 31, 2023 |
Annual revenue (TTM): | $0.29M as of Dec 31, 2023 |
EBITDA (TTM): | -$1.21M as of Dec 31, 2023 |
Net annual income (TTM): | -$1.64M as of Dec 31, 2023 |
Free cash flow (TTM): | -$1.35M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 218,309,152 as of Dec 31, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |